Kailera Therapeutics (KLRA) Net Margin (2025 - 2026)
Kailera Therapeutics (KLRA) reported Net Margin of -1379.72% for Q1 2026, down 306.11 percentage points from -1073.61% a year earlier.
Powered by 
Analysis
Kailera Therapeutics (KLRA) Net Margin (2025 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Kailera Therapeutics' Net Margin came in at -6962.08%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 19.55% |
| 10 | Kailera Therapeutics | 1.72 Bn | -1.16 Bn | - | - |
API Access
Kailera Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=KLRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "KLRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=KLRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();